NSE: PIIND · 11 November 2026
- Pi Industries has fallen 20.01% over 5 trading sessions; today's move is +2.03%.
- PI Industries submitted the outcome of its board meeting held on November 4, 2026, approving the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Consolidated revenue for the quarter stood at ₹17,018 million with an EBITDA of ₹2,362 million and a net profit of ₹1,222 million, reflecting domestic outperformance countered by global agrochemical export headwinds. Management noted that net working capital reduced by 18 days to 121 days, releasing ₹2,981 million in cash.
- Trading volume was 0.49 times the 20-day average daily volume.
Pi Industries share price: 20.01% decline over 5 trading sessions
PI Industries Ltd (PIIND) shares are trading higher by 2.03% at ₹1,747.70, moving near the higher end of the day's range of ₹1,717.30 to ₹1,757.90 after opening at ₹1,818.20.
The broader market has shown positive momentum, with the Nifty benchmark rising 1.23% and the Nifty Metal sector index advancing 0.78%. PI Industries' move comes against a backdrop of recent downward pressure, with the stock registering a 20.01% decline over the past 5 trading days and an 18.01% drop over the past 20 trading days.
Company disclosures highlight ongoing developments, including the recent November 4, 2026 earnings outcome for the quarter and half-year ended September 30, 2026, as well as the October 29, 2026 unveiling of Pioxaniliprole, India's first indigenously discovered insecticide molecule.
4.76 lakh shares traded by 11 November 2026 · 10:30 AM IST. This compares with a 20-day average daily volume of 9.66 lakh shares (0.49 times). The five-day average daily volume was 28.72 lakh shares. Separately, the NSE report for 9 November 2026 showed 6.45 lakh shares delivered, representing 40.13% of that day’s traded volume. The same report recorded 68,679 trades.
The stock is rising 2.03% today after suffering significant declines of 20.01% over the past 5 trading days and 18.01% over the past 20 trading days. In the absence of an immediate same-day catalyst, the price movement reflects a technical recovery supported by broader market gains.
Latest Company Developments
PI Industries submitted the outcome of its board meeting held on November 4, 2026, approving the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Consolidated revenue for the quarter stood at ₹17,018 million with an EBITDA of ₹2,362 million and a net profit of ₹1,222 million, reflecting domestic outperformance countered by global agrochemical export headwinds. Management noted that net working capital reduced by 18 days to 121 days, releasing ₹2,981 million in cash.
Provides official financial figures and operational insights regarding margin pressures and working capital improvements.
The company formally unveiled Pioxaniliprole, recognized as India's first indigenously discovered insecticide molecule developed through over a decade of research. The molecule received registration under section 9(3) of the Insecticides Act, 1968 from the Central Insecticides Board and Registration Committee (CIB&RC) for TIM and FIM categories under the brand name Pioxazon.
Highlights domestic proprietary innovation and expands the company's product pipeline for the domestic market.
PI Industries completed the incorporation of its wholly owned subsidiary, PI Foundation, as a not-for-profit organization under section 8 of the Companies Act, 2013. The entity was established with an initial cash subscription of ₹1,00,000 to carry out corporate social responsibility activities.
Formalizes the company's social responsibility structure as a wholly owned subsidiary.
PI Industries Limited has submitted to the Exchange, the Outcome of Board Meeting held on November 04, 2026 for approval of Unaudited Standalone and Consolidated Financial Results for the quarter and half year September 30, 2026.
Update on Incorporation of a Wholly Owned Subsidiary of the Company namely PI Foundation under section 8 of the Companies Act, 2013.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 22.18% on 30 September 2026. This compares with 22.31% on 30 June 2026, a change of -0.13 percentage points.
The filing reported 30 MF/UTI holders.
Historical Bulk / Block Deals
What to Watch Next
- Execution and market uptake of newly commercialized Pioxaniliprole (Pioxazon)
- Export demand recovery in the custom synthesis and manufacturing (CSM) segment
- Further trends in net working capital efficiency and cash generation
- Delivery volume participation relative to the 20-day average volume
Other Dated Coverage
- Pi Industries Share Price Today: Falls 21.68% in 3 Trading Sessions | 9 November 2026 — 9 November 2026
- Pi Industries Share Price Today: Falls 20.67% in 2 Trading Sessions | 6 November 2026 — 6 November 2026
- Pi Industries Share Price Today: Why PIIND Is Rising 3.27% | 27 October 2026 — 27 October 2026
More Pi Industries news and dated analysis →
Frequently Asked Questions
What is the latest Pi Industries company news?
PI Industries submitted the outcome of its board meeting held on November 4, 2026, approving the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Consolidated revenue for the quarter stood at ₹17,018 million with an EBITDA of ₹2,362 million and a net profit of ₹1,222 million, reflecting domestic outperformance countered by global agrochemical export headwinds. Management noted that net working capital reduced by 18 days to 121 days, releasing ₹2,981 million in cash.
How strong was Pi Industries’s trading volume?
4.76 lakh shares traded, 0.49 times the 20-day average daily volume. The price and volume data are dated 11 November 2026 · 10:30 AM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.